GSK to deliver 1 billion dosages of coronavirus antibody promoter in 2021 Kumar Jeetendra | May 28, 2020 GlaxoSmithKline Plc will grow creation of antibody adequacy boosters, or adjuvants, to deliver 1 billion portions in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday. The London-recorded organization said it was in converses with governments on sponsorship for the program, which would adequately take into account a scaling up of …
